FULL DAY WORKSHOP
Advances in Delivery Technology of Biologics: Proteins, Peptides, and Vaccines Delivery
Symposium Chairperson:
- Tomas Landh, Principal Scientist, Pre-formulation & Delivery, Novo Nordisk
- Christopher Rhodes, Senior Director, Drug Delivery Technology, Amylin
- Peter Hoffman, Vice President, New Technologies, Genzyme
9:15 PART 1
Systemic Delivery of Therapeutic siRNA: Opportunities and Challenges
- Xiaodong Yang, MD, PhD, Vice President, Research and Clinical Development, Intradig
9:45 PART 2
The Role of RNAi Compound Potency and Delivery in In Vivo Efficacy
- Joanne Kamens, PhD, Director of Discovery, RXI Pharm
10:15 PART 3
Novel Amino Acid Based Lipids (DiLA2) for the Delivery of siRNA
- Roger Adami, PhD, Associate Director of Molecular Pharmaceutics, MD RNA, Inc
10:45
30-Minute Networking & Refreshment Break
11:15 PART 4
The Development of SNALP Delivered siRNA Based Drugs
Ian MacLachlan, PhD, Executive VP and Chief Scientific Officer, Protiva Bio
11:45 PART 5
A Novel DNAi Being Developed for the Treatment of Cancer
Wendi Rodriguez, Pronai
12:15
Luncheon
1:30 PART 6
Vaxfectin (R) as an Adjuvant for DNA-Based Vaccines
Sean M. Sullivan, PhD, Executive Director of Pharmaceutical Sciences, Vical
2:00 Part 7
Case Study: Applications of Recombinant Human Hyaluronidase to Subcutaneous Delivery of Biologic
- Igor Bilinsky, Vice President, Business Development & Special Operations, Halozyme Therapeutics
2:30 Part 8
Advances in Vaccine Delivery For Faster and Smoother Development
- Charles Potter, PhD, Chief Executive Officer, Glide Pharmaceuticals
3:00
30 Minute Networking & Refreshment Break
3:30 Part 9
Case Studies: Advances in Oral Vaccine Delivery
- David Lechuga, PhD, Senior Director, Pharmaceutical R&D, Aridis Pharma
4:00
Panel Discussion and Audience Q&A
- Featuring all Workshop Leaders
4:30
Workshop Concludes
- Grand Opening Reception begins in Exhibit Hall
| Overview Half-Day Workshops | |
| 8:00 | Workshop Registration & Morning Coffee
|
| 9:00 | Workshop Begins; Opening remarks by workshop chairpersons |
| 10:30 | 30-minute Networking & Refreshment Break |
| 12:00 | Networking Luncheon for AM Workshop Participants; AM Workshops Conclude |
| 1:30 | Workshop Resumes; PM Workshops Begin |
| 3:00 | 30-minute Networking & Refreshment Break |
| 4:30 | Workshops Conclude, Grand Opening of Exhibit Hall |
AM HALF DAY WORKSHOP
Maximize Your Opportunities in OTC Drug Delivery
Workshop Leaders:
- Bob Nissen, Former VP, Business Development and Licensing, Novartis Consumer Health, New Technology Consultant, Bayer Healthcare
- Tim Saxon, Former AVP, Business Development, Wyeth Consumer Healthcare
- Thierry Bilbault, Vice President, New Technology & Product Innovation, Novartis Consumer Healthcare
- Dr. Markus Krumme, Vice President, LTS Corporation, Oral Delivery Systems
- Shingai Majuru- B.Pharm (HONS), MPhil (MED), MSC, PhD, Director of Formulations Development, US Research and Development, Banner
Part One
Introduction – The Growth of OTC Brands and the Value of Drug Delivery
Part Two
Advantages for OTC Companies in Using Drug Delivery for Life Cycle Management and Product Growth
- Shingai Majuru- B.Pharm (HONS), MPhil (MED), MSC, PhD, Director of Formulations Development, US Research and Development, Banner
Part Three
Oral Film Strips/Wafers: The Cutting Edge Drug Delivery System
- Dr. Markus Krumme, Vice President, LTS Corporation, Oral Delivery Systems
Part Four
Case Study: Success in Film Strips
- Thierry Bilbault, Vice President, New Technology & Product Innovation, Novartis Consumer Healthcare
AM HALF DAY WORKSHOP
Specialty Pharma Workshop – The True Costs of Outsourcing, Product Development, and Commercialization
Workshop Leaders:
- Brian Gabrio, Business Development Manager, 3M Drug Delivery Systems
- Robert More, Partner, Frazier
- Jackie Peterson, Manufacturing Services Business Manager, 3M Drug Delivery Systems
Part One
State of the Specialty Pharma Industry – Where are We Now?
- Robert More, Partner, Frazier
Part Two
Outsourcing Product Development and Commercialization: Considerations For Emerging Specialty Pharmaceutical Companies
- Brian Gabrio, Business Development Manager, 3M Drug Delivery Systems
- Jackie Peterson, Manufacturing Services Business Manager, 3M Drug Delivery Systems
PM HALF DAY WORKSHOP
The Role of Innovative Drug Delivery in the Treatment of Pain
Workshop Leader:
- Felix Theeuwes, D.Sc., Chairman and Chief Scientific Officer, Durect Corporation
Part One
How Drug Delivery Transformed the Pain Market
Part Two
Redcution in the Abuse Potential of Narcotics
Part Three
Improvements in Post-Surgical Pain Control and Reductions in Associated Side Effects
Part Four
Treating Local Pain Conditions
Part Five
Market Performance and Outlook for Pain-Focused Companies
Part Six
Recent Licensing and M&A Deals in the Pain Space
PM HALF DAY WORKSHOP
Identifying New Markets for Drug Delivery Technology: Differentiating Your Technology and Negotiating the Deal
Workshop Leaders:
- Vickie O’Neil, Vice President, Research & Technology, Upsher-Smith Laboratories
- Art Tipton, PhD, President & CEO, Brookwood
- Genzyme, speaker TBD
Part One
Got a great drug delivery technology or platform- How to Determine Target Markets
Part Two
How to Rise Above the Noise: Differentiating Yourself to Potential Partners In An Increasingly Competitive World
Part Three
Negotiating the Deal – Workshop Exercise
PM HALF DAY WORKSHOP
Drug/Device Combinations: Interactions, Regulations, and Market Potential
Part One
Case Study: Development of rhPDGF-BB Based Drug/Device Combination Products for the Treatment of Orthopedic Injuries and Diseases
- Charles E. Hart, PhD, Chief Scientific Officer, BioMimetic Therapeutics
Part Two
From Syringe to Autoinjector- Challenges and Pitfalls of Drugs in Devices
- Robin Hwang, PhD, Scientific Director, Amgen
Part Three
Drug/Device Combination Regulatory Considerations
- For more information on participating, please contact Tricia Carle-Sutton, TCarle@iirusa.com
Part Four
Drug/Device Market Potential
- For more information on participating, please contact Tricia Carle-Sutton, TCarle@iirusa.com